FR2988843B1 - METHOD FOR DETERMINING THE TUMOR OR NON-TUMOR NATURE OR TYPE OF TUMOR OF A HUMAN OR ANIMAL SOLID MEMBER FRAGMENT - Google Patents

METHOD FOR DETERMINING THE TUMOR OR NON-TUMOR NATURE OR TYPE OF TUMOR OF A HUMAN OR ANIMAL SOLID MEMBER FRAGMENT

Info

Publication number
FR2988843B1
FR2988843B1 FR1253057A FR1253057A FR2988843B1 FR 2988843 B1 FR2988843 B1 FR 2988843B1 FR 1253057 A FR1253057 A FR 1253057A FR 1253057 A FR1253057 A FR 1253057A FR 2988843 B1 FR2988843 B1 FR 2988843B1
Authority
FR
France
Prior art keywords
tumor
human
determining
type
nature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1253057A
Other languages
French (fr)
Other versions
FR2988843A1 (en
Inventor
Fabienne Bregeon
Didier Raoult
Jean-Marc Rolain
Xavier Benoit D'journo
Christophe Flaudrops
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Marseille APHM
Original Assignee
Assistance Publique Hopitaux de Marseille APHM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Marseille APHM filed Critical Assistance Publique Hopitaux de Marseille APHM
Priority to FR1253057A priority Critical patent/FR2988843B1/en
Priority to EP13719904.8A priority patent/EP2834628A1/en
Priority to PCT/FR2013/050586 priority patent/WO2013150204A1/en
Publication of FR2988843A1 publication Critical patent/FR2988843A1/en
Application granted granted Critical
Publication of FR2988843B1 publication Critical patent/FR2988843B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
FR1253057A 2012-04-03 2012-04-03 METHOD FOR DETERMINING THE TUMOR OR NON-TUMOR NATURE OR TYPE OF TUMOR OF A HUMAN OR ANIMAL SOLID MEMBER FRAGMENT Expired - Fee Related FR2988843B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1253057A FR2988843B1 (en) 2012-04-03 2012-04-03 METHOD FOR DETERMINING THE TUMOR OR NON-TUMOR NATURE OR TYPE OF TUMOR OF A HUMAN OR ANIMAL SOLID MEMBER FRAGMENT
EP13719904.8A EP2834628A1 (en) 2012-04-03 2013-03-19 Method for determining the tumoral or non-tumoral nature, or the tumor type, of a solid human or animal organ fragment
PCT/FR2013/050586 WO2013150204A1 (en) 2012-04-03 2013-03-19 Method for determining the tumoral or non-tumoral nature, or the tumor type, of a solid human or animal organ fragment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1253057A FR2988843B1 (en) 2012-04-03 2012-04-03 METHOD FOR DETERMINING THE TUMOR OR NON-TUMOR NATURE OR TYPE OF TUMOR OF A HUMAN OR ANIMAL SOLID MEMBER FRAGMENT

Publications (2)

Publication Number Publication Date
FR2988843A1 FR2988843A1 (en) 2013-10-04
FR2988843B1 true FR2988843B1 (en) 2016-12-09

Family

ID=48237066

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1253057A Expired - Fee Related FR2988843B1 (en) 2012-04-03 2012-04-03 METHOD FOR DETERMINING THE TUMOR OR NON-TUMOR NATURE OR TYPE OF TUMOR OF A HUMAN OR ANIMAL SOLID MEMBER FRAGMENT

Country Status (3)

Country Link
EP (1) EP2834628A1 (en)
FR (1) FR2988843B1 (en)
WO (1) WO2013150204A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3009088B1 (en) * 2013-07-24 2016-11-25 Assist Publique - Hopitaux De Marseille METHOD FOR DETECTING MICROBIAL CONTAMINATION OF A SAMPLE BY ANALYSIS OF MASS SPECTRUM
EP3511729A1 (en) * 2018-01-11 2019-07-17 Koninklijke Philips N.V. Magnetization transfer based metric for chemical exchange saturation transfer magnetic resonance imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961311B1 (en) * 2010-06-10 2013-04-05 Assist Publ Hopitaux Marseille METHOD FOR IDENTIFICATION OF EUKARYOTIC CELLS BY MALDI-TOF MASS SPECTROMETRY

Also Published As

Publication number Publication date
FR2988843A1 (en) 2013-10-04
WO2013150204A1 (en) 2013-10-10
EP2834628A1 (en) 2015-02-11

Similar Documents

Publication Publication Date Title
IL257141A (en) Biological markers for identifying patients for treatment with vegf antagonists
CO6910184A2 (en) New compounds for the treatment of diseases associated with amyloid or amyloid proteins
DK2534173T3 (en) Manipulated cleavage half-domains
BRPI0921805A2 (en) antibodies that specifically block the biological activity of a tumor antigen
CR20130406A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HUMAN ANTIBODIES AGAINST PCSK9
DK2580243T3 (en) ANTIBODIES AGAINST HUMAN CD38
ES2685958T8 (en) Procedure for the early detection of trains
BR112012029866A2 (en) method for determining the presence of a steap-1 protein
BR112013009970A2 (en) method for determining a characteristic of a patient's circadian rhythm.
HK1186767A1 (en) A method of analysing a blood sample of a subject for the presence of a disease marker
DK2593797T3 (en) UNKNOWN PROCEDURES FOR PROTEIN EVOLUTION
FR2980271B1 (en) METHOD FOR DETERMINING GLYCOSYLATION OF ANTIBODY
HK1208503A1 (en) Euglobulin-based method for determining the biological activity of defibrotide
CY2020015I2 (en) Ciclesonide for the Treatment of Airway Disease in Horses
FR2962823B1 (en) SITUATION ANALYSIS PROCESSOR
FI20115607A0 (en) Cheese and the method of making it
EP2731965A4 (en) Identifying affinity-matured human antibodies
ES2641042T8 (en) Procedure for the manufacture of a protein drug
FR2994821B1 (en) IMPROVED ELECTROPHYSIOLOGICAL ANALYSIS SYSTEM
BR112013029857A2 (en) methods and compositions for determining heart failure or risk of heart failure
FR2996008B1 (en) METHOD FOR EVALUATING A METHOD OF DETERMINING THE RECOVERED DOSE DURING RADIOTHERAPY TREATMENT
JP2014529605A5 (en) Protein comprising NC-1 for treating angiogenesis-related diseases
IT1404710B1 (en) EQUIPMENT FOR DETERMINING DETOURAGE
FR2963372B1 (en) PREFABRICATED ELEMENT FOR THE PASSAGE OF TECHNICAL SHEATH.
ES2369102B8 (en) PROCEDURE FOR OBTAINING HEALTHY MEAT PRODUCTS WITH ALGAE.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20201214